IntrinsicIntrinsic
← All summaries

Aldabra 4 Liquidity Opportunity Vehicle, Inc.

ALOVU
Financials & Chart →

Business Summary

Aldabra 4 Liquidity Opportunity Vehicle, Inc. (the "Company") is a Cayman Islands exempted blank check company formed on July 24, 2025, with the sole purpose of effecting a business combination, such as a merger, amalgamation, share exchange, or asset acquisition, with one or more operating businesses or entities . The Company has not yet selected a target business and has not initiated any substantive discussions with potential targets . Its business model is to identify and acquire a target company, then implement or support the acquired company's operating strategies to generate additional value for shareholders, potentially through further acquisitions and operational improvements . The Company intends to seek an initial business combination with a company that has an enterprise value between $500 million and $2 billion, though smaller or larger targets may be considered . The Company's efforts to identify a prospective target business are not limited to a particular industry or geographic region .

The Company's core business model is that of a Special Purpose Acquisition Company (SPAC), which involves raising capital through an Initial Public Offering (IPO) and a private placement, placing the majority of these proceeds into a trust account, and then using these funds to acquire an existing operating business. Revenue generation is not expected until after the completion of an initial business combination . The primary customer segments are not applicable as the Company is a blank check company seeking an acquisition. The Company's structure offers a target business an alternative to a traditional IPO, potentially providing a more expeditious and cost-effective method to becoming a public company .

For the period from July 24, 2025 (inception) through December 31, 2025, the Company reported a net loss of $78,082 . As of December 31, 2025, the Company had cash of $23,583 and a working capital deficit of $314,563 . Total assets were $285,064 , and total liabilities were $338,146 . The shareholder's deficit amounted to $(53,082) , comprising Class B ordinary shares of $750 , additional paid-in capital of $24,250 , and an accumulated deficit of $(78,082) . Basic and diluted net loss per Class B ordinary share was $(0.01) , based on 6,525,000 weighted average Class B shares outstanding .

Subsequent to the reporting period, on January 23, 2026, the Company consummated its Initial Public Offering of 30,015,000 units, including the full exercise of the underwriters' over-allotment option of 3,915,000 units, at $10.00 per unit, generating gross proceeds of $300,150,000 . Simultaneously, a private placement of 4,866,666 private placement warrants was completed at $1.50 per warrant, generating gross proceeds of $7,300,000 . Of these, the Sponsor purchased 3,126,666 warrants and the underwriters purchased 1,740,000 warrants . A total of $300,150,000 from the net proceeds of the IPO and private placement was placed in a Trust Account . Total transaction costs amounted to $18,350,595 , consisting of $5,220,000 in cash underwriting fees , $12,789,000 in deferred underwriting fees , and $341,595 in other offering costs .

During the period from July 24, 2025 (inception) through December 31, 2025, net cash used in operating activities was $33,711 . This was primarily driven by a net loss of $78,082 , partially offset by a $20,000 payment of general and administrative costs through a promissory note , an increase in accounts payable of $11,246 , and an increase in accrued expenses of $13,125 . Net cash provided by financing activities was $57,294 , resulting from $180,000 in proceeds from a related-party promissory note , offset by $122,706 in payments for deferred offering costs .

The Company's operational developments during the reported period were limited to organizational activities and preparations for its IPO . No product launches, acquisitions, or partnerships were undertaken as the Company is a blank check company. The Company incurred formation, general and administrative expenses of $78,082 .

Business Outlook

The Company intends to use substantially all of the funds held in the Trust Account, including any interest earned thereon (less taxes payable), to complete its initial Business Combination . If share capital or debt is used as consideration for the Business Combination, the remaining proceeds in the Trust Account will be allocated as working capital for the target business's operations, other acquisitions, and growth strategies . Funds held outside the Trust Account are primarily designated for identifying and evaluating target businesses, conducting due diligence, travel, reviewing corporate documents, and structuring and completing a Business Combination .

The Company's primary growth area is the successful identification and consummation of an initial business combination with a target company that has an enterprise value between $500 million and $2 billion . The Company's objective post-combination is to implement or support the acquired company's operating strategies to generate additional shareholder value, which may include further acquisitions and operational improvements . The Company's management team believes its experience, reputation, and network will enable it to identify high-growth businesses with proven or potential transnational operations or outlooks . The Company has until January 23, 2028, which is 24 months from the closing of the IPO, to complete a Business Combination .

Regarding margin trajectory and cost structure, the Company does not expect to generate operating revenues until after the completion of its initial business combination . Post-IPO, it will generate non-operating income from interest on marketable securities in the Trust Account . The Company anticipates incurring expenses as a public company for legal, financial reporting, accounting, and auditing compliance, as well as for due diligence expenses related to its acquisition plans . The Sponsor has agreed to loan the Company funds up to $1,500,000 to finance transaction costs in connection with a business combination, which may be convertible into private placement warrants at $1.00 per warrant .

The Company's capital allocation plans include using the net proceeds from the IPO and private placement for its initial business combination. The Trust Account holds $300,150,000 . The Company will reimburse its Sponsor $30,000 per month for office space, utilities, and administrative support until the completion of a business combination or liquidation . The underwriters are entitled to a deferred underwriting fee of $12,789,000 , payable from the Trust Account upon completion of a Business Combination . The holders of Founder Shares, Private Placement Warrants, and private placement-equivalent warrants from working capital loans have registration rights, with the Company bearing the expenses of registering these securities .

The Company faces structural headwinds and execution risks, including intense competition from other entities, such as private investors and other SPACs, for attractive target businesses, which could lead to increased demand for improved financial terms . The ability of public shareholders to redeem their shares for cash may make the Company's financial condition unattractive to potential targets, potentially hindering the completion of a business combination . If too many public shareholders exercise redemption rights, the Company might not meet minimum cash requirements for a closing condition, forcing it to restructure or abandon a transaction . The deferred underwriting compensation of $12,789,000 will not be adjusted for redemptions, which could dilute the per-share value for non-redeeming shareholders . The requirement to complete a business combination within 24 months may give target businesses leverage in negotiations and limit due diligence time . Geopolitical conditions, such as the Russia-Ukraine conflict and Middle East tensions, could adversely affect the search for a target and the operations or financial condition of potential targets .

Risk Factors

The Company faces material risks including intense competition for business combination opportunities from other SPACs and private investors, which could lead to increased costs or an inability to find a suitable target . The ability of public shareholders to redeem their shares for cash may make the Company's financial condition unattractive to potential targets, potentially preventing the completion of a business combination if minimum cash requirements are not met . The deferred underwriting commissions of $12,789,000 will not be adjusted for redemptions, potentially diluting the investment of non-redeeming shareholders . The Company has a 24-month deadline from the IPO closing (January 23, 2028) to complete a business combination , which could give target businesses leverage in negotiations and limit due diligence time . Geopolitical instability, such as the ongoing Russia-Ukraine conflict and Middle East tensions, could lead to market disruptions, volatility in capital markets, supply chain interruptions, and increased cyber-attacks, adversely affecting the Company's search for a target or the operations of a post-combination business . Changes in laws or regulations, particularly the SEC's new SPAC Rules, may increase costs and time needed to complete a business combination and could lead to the Company being deemed an investment company, imposing burdensome compliance requirements or restricting its activities . If the Company is deemed an investment company, it may be forced to liquidate, resulting in public shareholders receiving only approximately $10.00 per share and warrants expiring worthless . The nominal purchase price of $0.003 per share paid by initial shareholders for founder shares may result in significant dilution to public shareholders upon a business combination, and initial shareholders are likely to make a substantial profit even if the trading price of ordinary shares declines .

Management Priorities

Management's message emphasizes their extensive experience in identifying, evaluating, and consummating business combinations, citing prior successes with Aldabra 1, Aldabra 2, and Terrapin 3 . They believe this experience will be a positive factor for potential target sellers . The Company's strategic priorities are centered on identifying a high-growth business with an enterprise value between $500 million and $2 billion , implementing operational improvements post-acquisition, and potentially pursuing additional acquisitions . Management acknowledges that their network and experience do not guarantee a successful initial business combination . They also highlight that officers and directors are not required to devote full-time to the Company's affairs and may have conflicts of interest due to other business endeavors . The Company will reimburse its sponsor $30,000 per month for administrative services, and up to $1,500,000 in working capital loans from the sponsor or affiliates may be converted into private placement warrants at $1.50 per warrant upon a business combination.

View Source Annual Report on SEC.gov ↗

References

  1. [1] Item 1, Business — Overview
  2. [2] Item 7, MD&A — Overview
  3. [3] Item 1, Business — Overview
  4. [4] Item 1, Business — Overview
  5. [5] Item 1, Business — Overview
  6. [6] Item 7, MD&A — Results of Operations
  7. [7] Item 1, Business — Status as a Public Company
  8. [8] Item 7, MD&A — Results of Operations
  9. [9] Item 7, MD&A — Liquidity and Capital Resources
  10. [10] Item 7, MD&A — Liquidity and Capital Resources
  11. [11] Item 8, Balance Sheet
  12. [12] Item 8, Balance Sheet
  13. [13] Item 8, Balance Sheet
  14. [14] Item 8, Balance Sheet
  15. [15] Item 8, Balance Sheet
  16. [16] Item 8, Balance Sheet
  17. [17] Item 8, Statement of Operations
  18. [18] Item 8, Statement of Operations
  19. [19] Item 7, MD&A — Liquidity and Capital Resources
  20. [20] Item 7, MD&A — Liquidity and Capital Resources
  21. [21] Item 7, MD&A — Liquidity and Capital Resources
  22. [22] Item 7, MD&A — Liquidity and Capital Resources
  23. [23] Item 7, MD&A — Liquidity and Capital Resources
  24. [24] Item 7, MD&A — Liquidity and Capital Resources
  25. [25] Item 7, MD&A — Liquidity and Capital Resources
  26. [26] Item 7, MD&A — Liquidity and Capital Resources
  27. [27] Item 7, MD&A — Liquidity and Capital Resources
  28. [28] Item 7, MD&A — Liquidity and Capital Resources
  29. [29] Item 7, MD&A — Liquidity and Capital Resources
  30. [30] Item 7, MD&A — Liquidity and Capital Resources
  31. [31] Item 7, MD&A — Liquidity and Capital Resources
  32. [32] Item 7, MD&A — Liquidity and Capital Resources
  33. [33] Item 7, MD&A — Liquidity and Capital Resources
  34. [34] Item 7, MD&A — Liquidity and Capital Resources
  35. [35] Item 7, MD&A — Liquidity and Capital Resources
  36. [36] Item 7, MD&A — Results of Operations
  37. [37] Item 7, MD&A — Results of Operations
  38. [38] Item 7, MD&A — Liquidity and Capital Resources
  39. [39] Item 7, MD&A — Liquidity and Capital Resources
  40. [40] Item 7, MD&A — Liquidity and Capital Resources
  41. [41] Item 1, Business — Overview
  42. [42] Item 1, Business — Overview
  43. [43] Item 1, Business — Acquisition Criteria
  44. [44] Item 1, Business — Initial Business Combination
  45. [45] Item 7, MD&A — Results of Operations
  46. [46] Item 7, MD&A — Results of Operations
  47. [47] Item 7, MD&A — Results of Operations
  48. [48] Item 7, MD&A — Liquidity and Capital Resources
  49. [49] Item 7, MD&A — Liquidity and Capital Resources
  50. [50] Item 7, MD&A — Liquidity and Capital Resources
  51. [51] Item 7, MD&A — Contractual Obligations
  52. [52] Item 7, MD&A — Contractual Obligations
  53. [53] Item 7, MD&A — Contractual Obligations
  54. [54] Item 7, MD&A — Contractual Obligations
  55. [55] Item 1, Business — Competition
  56. [56] Item 1A, Risk Factors — Risks Related to our Search for, Consummation of, or Inability to Consummate, a Business Combination
  57. [57] Item 1A, Risk Factors — Risks Related to our Search for, Consummation of, or Inability to Consummate, a Business Combination
  58. [58] Item 7, MD&A — Contractual Obligations
  59. [59] Item 1A, Risk Factors — Risks Related to our Search for, Consummation of, or Inability to Consummate, a Business Combination
  60. [60] Item 1, Business — Initial Business Combination
  61. [61] Item 1A, Risk Factors — Risks Related to our Search for, Consummation of, or Inability to Consummate, a Business Combination
  62. [62] Item 1A, Risk Factors — Risks Related to our Search for, Consummation of, or Inability to Consummate, a Business Combination
  63. [63] Item 1A, Risk Factors — Risks Related to our Search for, Consummation of, or Inability to Consummate, a Business Combination
  64. [64] Item 1A, Risk Factors — Risks Related to our Search for, Consummation of, or Inability to Consummate, a Business Combination
  65. [65] Item 7, MD&A — Contractual Obligations
  66. [66] Item 1A, Risk Factors — Risks Related to our Search for, Consummation of, or Inability to Consummate, a Business Combination
  67. [67] Item 1, Business — Initial Business Combination
  68. [68] Item 1A, Risk Factors — Risks Related to our Search for, Consummation of, or Inability to Consummate, a Business Combination
  69. [69] Item 1A, Risk Factors — Risks Related to our Search for, Consummation of, or Inability to Consummate, a Business Combination
  70. [70] Item 1A, Risk Factors — Risks Related to our Search for, Consummation of, or Inability to Consummate, a Business Combination
  71. [71] Item 1A, Risk Factors — Risks Related to our Search for, Consummation of, or Inability to Consummate, a Business Combination
  72. [72] Item 1A, Risk Factors — Risks Related to our Search for, Consummation of, or Inability to Consummate, a Business Combination
  73. [73] Item 1A, Risk Factors — Risks Related to Our Securities
  74. [74] Item 1A, Risk Factors — Risks Related to Our Securities
  75. [75] Item 1A, Risk Factors — Risks Related to Our Securities
  76. [76] Item 1A, Risk Factors — Risks Related to Our Securities
  77. [77] Item 1A, Risk Factors — Risks Related to Our Securities
  78. [78] Item 1, Business — Our Management Team
  79. [79] Item 1, Business — Prior SPAC Experience
  80. [80] Item 1, Business — Overview
  81. [81] Item 1, Business — Overview
  82. [82] Item 1, Business — Our Management Team
  83. [83] Item 1A, Risk Factors — Risks Relating to our Management Team
  84. [84] Item 7, MD&A — Contractual Obligations
  85. [85] Item 7, MD&A — Liquidity and Capital Resources
  86. [86] Item 7, MD&A — Liquidity and Capital Resources

Analysis on 5/19/2026